Pharma Manufacturers & Distributors Special - 2026

Pharma Manufacturers & Distributors Special - 2026

Pharma Manufacturers & Distributors Special - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products and services.

“Process Analytical Technology (PAT) is central to AURUS’ vision for the next phase of pharmaceutical machinery” - Aurus Pharma Machinery

“As Liport expands, the company is simultaneously strengthening the systems and people required to support sustainable growth” - LIPORT HEALTHCARE

“Nahush Pharmaceuticals' approach combines material functionality with a deliberately simple product format” - NAHUSH PHARMACEUTICALS

“Nidramed values its stakeholders as vital intellectual capital and encourages deep functional ownership, grounded in the decisive vision of its founders” - NIDRAMED HEALTH SOLUTIONS

“Nootan Pharmaceuticals intends to deepen its relationships with existing manufacturers while actively approaching additional pharmaceutical companies for authorized stockist opportunities” - NOOTAN PHARMACEUTICALS

“When a pharmaceutical company has a critical equipment or process requirement, Saksham should be among the first...

Pharma Manufacturers & Distributors Special - 2026

Aurus Pharma Machinery Aurus Pharma Machinery Aurus Pharma Machinery Pharmaceutical manufacturing demands equipment that can deliver consistent performance across complex and varied processing requirements.
Liport Healthcare Liport Healthcare Liport Healthcare India’s growing burden of diabetes and cardiovascular disease, alongside increasingly complex critical-care requirements, is placing greater responsibility on the healthcare ecosystem.
Nahush Pharmaceuticals Nahush Pharmaceuticals Nahush Pharmaceuticals In trauma and emergency care, the time between injury and definitive medical treatment can determine outcomes. Severe external bleeding is particularly challenging when an injured person is far from a hospital or when conventional pressure alone is insufficient.
Nidramed Health Solutions Nidramed Health Solutions Nidramed Health Solutions Coronary intervention is a field where technology and timely availability must work in tandem. Even a sophisticated device has limited clinical value if the required specification or size is unavailable when an interventional cardiologist needs it.
Saksham Technologies Saksham Technologies Saksham Technologies Pharmaceutical laboratory equipment distribution has moved far beyond supplying instruments from global manufacturers to local customers.
Sripath Medical Systems Sripath Medical Systems Sripath Medical Systems Wound care is increasingly moving beyond conventional dressings towards solutions designed to address the underlying barriers that delay healing.
Nootan Pharmaceuticals Nootan Pharmaceuticals Nootan Pharmaceuticals India’s oncology ecosystem is becoming increasingly complex as treatment protocols expand beyond conventional chemotherapy to include targeted therapies, immunotherapies, precision medicines and advanced supportive care.

© 2026 India Pharma Outlook. All Rights Reserved.